Basic information on COVID-19 pandemic, due to SARS-Cov-2 Virus
The World Health Organization (WHO) declared the SARS-CoV-2 virus outbreak an internationally important public health emergency on 30 January 2020, and by 11 March declared it a pandemic. By 15 November 2020, according to the WHO weekly report, there were 53.7 million confirmed cases and 1.3 mil...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
2020
|
Subjects: | |
Online Access: | https://dialnet.unirioja.es/servlet/oaiart?codigo=8696957 |
Source: | Revista Análisis Jurídico-Político, ISSN 2665-5470, Vol. 2, Nº. 4, 2020 (Ejemplar dedicado a: Julio - Diciembre), pags. 29-47 |
Tags: |
Add Tag
No Tags: Be the first to tag this record
|
id |
dialnet-ar-18-ART0001563594
|
---|---|
record_format |
dialnet
|
institution |
Dialnet
|
collection |
Dialnet AR
|
source |
Revista Análisis Jurídico-Político, ISSN 2665-5470, Vol. 2, Nº. 4, 2020 (Ejemplar dedicado a: Julio - Diciembre), pags. 29-47
|
language |
Spanish
|
topic |
SARS-CoV-2
COVID-19 pandemia SARS-CoV-2 COVID-19 pandemic |
spellingShingle |
SARS-CoV-2
COVID-19 pandemia SARS-CoV-2 COVID-19 pandemic Miranda Novales, María Guadalupe Allier Montaño, Eugenia Aragón Nogales, Ranferi Basic information on COVID-19 pandemic, due to SARS-Cov-2 Virus |
description |
The World Health Organization (WHO) declared the SARS-CoV-2 virus outbreak an internationally important public health emergency on 30 January 2020, and by 11 March declared it a pandemic. By 15 November 2020, according to the WHO weekly report, there were 53.7 million confirmed cases and 1.3 million deaths reported globally. The Americas region is the most affected. The incubation period has been documented between 3 and 6 days. Transmission occurs from person to person by respiratory droplets, which occur when a person speaks, coughs or sneezes. The clinical presentation can range from a mild respiratory disease, with coughing, headache, and general discomfort, which resolves in a few days, to a severe disease with shortness of breath, that requires immediate attention. Global lethality reported as of November 26 is 2.3%. It is higher in people over the age of 65 and with underlying diseases such as high blood pressure, obesity, and diabetes. There is currently no specific antiviral treatment. Vaccines are in development and several of them have shown promising results, but there is still a need to conclude with global trials. Until vaccination can be initiated, prevention and control measures should be continued. The best way to prevent the disease is to avoid exposure to infected or possibly infected people, as the virus can be transmitted even if the person has no symptoms.
|
format |
Article
|
author |
Miranda Novales, María Guadalupe
Allier Montaño, Eugenia Aragón Nogales, Ranferi |
author_facet |
Miranda Novales, María Guadalupe
Allier Montaño, Eugenia Aragón Nogales, Ranferi |
author_sort |
Miranda Novales, María Guadalupe
|
title |
Basic information on COVID-19 pandemic, due to SARS-Cov-2 Virus
|
title_short |
Basic information on COVID-19 pandemic, due to SARS-Cov-2 Virus
|
title_full |
Basic information on COVID-19 pandemic, due to SARS-Cov-2 Virus
|
title_fullStr |
Basic information on COVID-19 pandemic, due to SARS-Cov-2 Virus
|
title_full_unstemmed |
Basic information on COVID-19 pandemic, due to SARS-Cov-2 Virus
|
title_sort |
basic information on covid-19 pandemic, due to sars-cov-2 virus
|
publishDate |
2020
|
url |
https://dialnet.unirioja.es/servlet/oaiart?codigo=8696957
|
_version_ |
1752873942244130816
|
spelling |
dialnet-ar-18-ART00015635942022-12-17Basic information on COVID-19 pandemic, due to SARS-Cov-2 VirusMiranda Novales, María GuadalupeAllier Montaño, EugeniaAragón Nogales, RanferiSARS-CoV-2COVID-19pandemiaSARS-CoV-2COVID-19pandemicThe World Health Organization (WHO) declared the SARS-CoV-2 virus outbreak an internationally important public health emergency on 30 January 2020, and by 11 March declared it a pandemic. By 15 November 2020, according to the WHO weekly report, there were 53.7 million confirmed cases and 1.3 million deaths reported globally. The Americas region is the most affected. The incubation period has been documented between 3 and 6 days. Transmission occurs from person to person by respiratory droplets, which occur when a person speaks, coughs or sneezes. The clinical presentation can range from a mild respiratory disease, with coughing, headache, and general discomfort, which resolves in a few days, to a severe disease with shortness of breath, that requires immediate attention. Global lethality reported as of November 26 is 2.3%. It is higher in people over the age of 65 and with underlying diseases such as high blood pressure, obesity, and diabetes. There is currently no specific antiviral treatment. Vaccines are in development and several of them have shown promising results, but there is still a need to conclude with global trials. Until vaccination can be initiated, prevention and control measures should be continued. The best way to prevent the disease is to avoid exposure to infected or possibly infected people, as the virus can be transmitted even if the person has no symptoms.La Organización Mundial de la Salud (OMS) declaró al brote por el virus SARS-CoV-2 como una emergencia de salud pública de importancia internacional el día 30 de enero de 2020, y para el 11 de marzo hizo la declaratoria de pandemia. Para el 15 noviembre de 2020, de acuerdo con el informe semanal de la OMS, se reportaron de forma global 53.7 millones de casos confirmados, y 1.3 millones de defunciones. La región de las Américas es la más afectada. El periodo de incubación ha sido documentado entre 3 a 6 días. La transmisión ocurre de persona a persona gotas respiratorias, que se producen cuando una persona habla, tose o estornuda. El cuadro clínico puede ir desde una enfermedad respiratoria leve, con tos, cefalea, malestar general, que resuelve en unos días, hasta un cuadro grave con dificultad respiratoria que requiere atención inmediata. La letalidad global mundial reportada al 26 de noviembre es de 2.3%, es mayor en personas mayores de 65 años y con enfermedades subyacentes como hipertensión arterial, obesidad, y diabetes. Al momento no se cuenta con un tratamiento antiviral específico. Las vacunas están en desarrollo y varias de ellas han mostrado resultados prometedores, pero falta concluir con los ensayos. En tanto se puede iniciar la vacunación, se debe continuar con las medidas de prevención y control. La mejor forma de prevenir la enfermedad es evitar exponerse a personas infectadas o posiblemente infectadas, ya que el virus puede transmitirse aún si la persona no tiene síntomas.2020text (article)application/pdfhttps://dialnet.unirioja.es/servlet/oaiart?codigo=8696957(Revista) ISSN 2665-5489(Revista) ISSN 2665-5470Revista Análisis Jurídico-Político, ISSN 2665-5470, Vol. 2, Nº. 4, 2020 (Ejemplar dedicado a: Julio - Diciembre), pags. 29-47spaLICENCIA DE USO: Los documentos a texto completo incluidos en Dialnet son de acceso libre y propiedad de sus autores y/o editores. Por tanto, cualquier acto de reproducción, distribución, comunicación pública y/o transformación total o parcial requiere el consentimiento expreso y escrito de aquéllos. Cualquier enlace al texto completo de estos documentos deberá hacerse a través de la URL oficial de éstos en Dialnet. Más información: https://dialnet.unirioja.es/info/derechosOAI | INTELLECTUAL PROPERTY RIGHTS STATEMENT: Full text documents hosted by Dialnet are protected by copyright and/or related rights. This digital object is accessible without charge, but its use is subject to the licensing conditions set by its authors or editors. Unless expressly stated otherwise in the licensing conditions, you are free to linking, browsing, printing and making a copy for your own personal purposes. All other acts of reproduction and communication to the public are subject to the licensing conditions expressed by editors and authors and require consent from them. Any link to this document should be made using its official URL in Dialnet. More info: https://dialnet.unirioja.es/info/derechosOAI
|